Search results for "Coronavirus"
New research on Pfizer pill, mental disorders after COVID-19, vaccine reactions
A manufacturer-funded trial quantified the effectiveness of nirmatrelvir/ritonavir in outpatients. A retrospective study found veterans had more mental health diagnoses and received more antidepressants, benzodiazepines, and opioids after COVID-19, while two other studies looked at reactions to second and third doses of the vaccines.
https://immattersacp.org/weekly/archives/2022/02/22/1.htm
22 Feb 2022
ACP, Annals of Internal Medicine host fifth forum on COVID-19
“COVID-19 Forum V: Evaluation and Care of Patients with Persistent Symptoms Following Acute SARS-CoV-2 Infection” was held on June 9.
https://immattersacp.org/weekly/archives/2021/06/15/2.htm
15 Jun 2021
New research on PASC, COVID-19 infection and vaccination during pregnancy
Two studies analyzed postacute sequelae of COVID-19 (PASC) in older and ICU patients. Other new research showed that symptomatic infection during delivery raised risks in pregnant women but vaccination during pregnancy was safe. An ACP/Annals of Internal Medicine forum focused on outpatient management of COVID-19, and the FDA issued an emergency use authorization for a new monoclonal antibody treatment.
https://immattersacp.org/weekly/archives/2022/02/15/1.htm
15 Feb 2022
New research on mixed vaccine boosters, long-term outcomes, omicron severity
A study found mixing and matching of COVID-19 vaccines to be safe and effective, other research showed ongoing symptoms to be common at one year after infection, the CDC analyzed the severity of omicron, and the FDA revised outpatient treatment authorizations.
https://immattersacp.org/weekly/archives/2022/02/01/1.htm
1 Feb 2022
Research on COVID-19 vaccines' duration, reactions, prioritization
Antibodies persisted six months after vaccination, and a graded dosing protocol allowed patients with reactions to a first shot to get a second. Surveyed Americans wanted to prioritize front-line workers and those with chronic conditions for vaccination, and a columnist finds reasons for hope.
https://immattersacp.org/weekly/archives/2021/04/13/1.htm
13 Apr 2021
Risk of re-infection, benefits of anticoagulation, cause of sex differences among COVID-19 research
Researchers published evidence of re-infection with SARS-CoV-2, anticoagulation was associated with halved inpatient mortality, recommendations were made on pulmonary embolism in COVID-19, and a study attributed differences in men's and women's outcomes to T cells.
https://immattersacp.org/weekly/archives/2020/09/01/2.htm
1 Sep 2020
New research on booster doses, breakthrough infections, long-term COVID-19 symptoms
A vaccine booster significantly reduced risk of severe disease or death from COVID-19, full vaccination provided more protection than previous infection, many patients reporting persistent symptoms did not have antibodies to SARS-CoV-2, and a trial of outpatient treatment was ineffective, recent studies found.
https://immattersacp.org/weekly/archives/2021/11/09/1.htm
9 Nov 2021
Regulatory changes for COVID-19 vaccine; data on waning immunity, outpatient therapies
The FDA authorized vaccinating children, the NIH supported concurrent use of flu and COVID-19 shots, and the CDC addressed a fourth dose of COVID-19 vaccine for the immunocompromised. Trials found benefit from a new monoclonal antibody and an old antidepressant for high-risk outpatients.
https://immattersacp.org/weekly/archives/2021/11/02/1.htm
2 Nov 2021
More data on risk factors for poor COVID-19 outcomes, mixed results from treatment trials
A risk calculator, genetic findings, and red blood cell distribution width helped predict severity of and death from COVID-19. Tocilizumab showed benefit, but a number of other treatments, including CPR, did not, according to recent research.
https://immattersacp.org/weekly/archives/2020/09/29/2.htm
29 Sep 2020
Breakthrough infections, cardiovascular effects of COVID-19, pandemic mental health
Two new studies reported on infections in fully vaccinated people, while another looked at the rate of myocardial infarction and stroke in patients with COVID-19. A survey found depression and anxiety to be common during the pandemic, and the push for mandatory vaccination of health care workers continued.
https://immattersacp.org/weekly/archives/2021/08/03/4.htm
3 Aug 2021